ARCA BIOPHARMA INC - COM (ABIO)

CUSIP: 00211Y506

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
1,132,828
Share change
+12,150
Total reported value
$2,603,860
Put/Call ratio
59%
Price per share
$2.30
Number of holders
19
Value change
+$47,546
Number of buys
9
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARCA BIOPHARMA INC - COM (ABIO) as of Q1 2022

As of 31 Mar 2022, ARCA BIOPHARMA INC - COM (ABIO) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,132,828 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, Tekla Capital Management LLC, Virtu Financial LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP. This page lists 19 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.